Hanover Bancorp, Inc.

HNVR

NASDAQBanks - Regional

+10.9%

since IPO

IPO Price

$21.00

Current Price

$23.30

Return

+10.9%▲

Market Cap

$166.8M

IPO Date

May 11, 2022

Lockup End

Nov 7, 2022

Lockup Status

Lockup expired 1269days ago

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price

IPO Price

Lockup End

Performance Summary

First Day

N/A

1 Month

N/A

3 Months

N/A

6 Months

N/A

1 Year

N/A

Since IPO

+10.9%

Hanover Bancorp, Inc. (HNVR) — IPO Analysis

By Kian O Connor | Updated 4/29/2026

Company Overview

Hanover Bancorp, Inc. (ticker: HNVR) specializes in core business operations while maintaining strategic capabilities in competitive advantages, positioning itself within the Banks - Regional sector through quality standards and niche market expertise. The company has developed its operations around market leadership, creating market differentiation through specialized expertise and subscription-based recurring revenue that supports sustainable growth and customer relationship development. The company completed its public offering on 2022-05-11, accessing capital markets during customer demand shifts within the Banks - Regional landscape. The IPO timing reflected the company's strategic positioning and growth trajectory, with market reception emphasizing management's execution capabilities and the company's approach to core business operations as key value creation drivers in an evolving competitive environment. Post-IPO trading performance has demonstrated positive market validation with ongoing investor evaluation of competitive positioning and execution capabilities. Market assessment focuses on the company's quality standards and strategic emphasis on competitive advantages as indicators of long-term competitive positioning within the Banks - Regional sector, with investors evaluating operational execution and market opportunity capture relative to industry development trends. The lockup period expires April 22, 2023, providing market insights into management and early investor confidence in strategic direction and competitive positioning. Given the company's focus on core business operations and emphasis on market leadership, insider trading decisions will likely reflect assessments of execution progress, competitive dynamics, and growth opportunity realization within the evolving Banks - Regional market landscape.

Performance Overview

Since going public at $21.00 per share on May 11, 2022, Hanover Bancorp, Inc. shares have gained 10.9%, rewarding investors who participated in the IPO. The stock currently trades at $23.30, giving the company a market capitalization of $166.8M.

Lockup Expiration

The lockup period for Hanover Bancorp, Inc. expired 1269 days ago on Nov 7, 2022. Insiders and early investors are now free to sell their pre-IPO shares. The post-lockup trading period is often volatile as the market absorbs any additional supply from insider selling.

Industry Context

Hanover Bancorp, Inc. operates in the Banks - Regional sector, which has seen varied IPO activity in recent years. The company is headquartered in the United States and is classified under SIC code . Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing HNVR as an investment.

Trading History

Hanover Bancorp, Inc. is actively trading in the public markets with a current share price of $23.30. The company went public at $21.00 per share, resulting in gains of 10.9% for IPO investors. With a current market capitalization of $166.8M, Hanover Bancorp, Inc. continues to establish its presence as a publicly traded entity in the Banks - Regional.

Important Disclaimer

This analysis of Hanover Bancorp, Inc. (HNVR) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

2

Pre-Expiry Average

Minimal

74

Expiry Day

High

56

Post-Expiry (30d)

High

Activity Heatmap

60 days before/after lockup expiry

Intensity Scale:

Minimal

Low

Moderate

High

Very High

Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Similar IPOs

Companies with similar industry, market cap, or IPO timing

Same IndustrySame ExchangeSimilar Size

CBK

Commercial Bancgroup, Inc.

Same IndustrySame Exchange

CBNA

Chain Bridge Bancorp, Inc.

Same IndustrySimilar Size

TCBX

Third Coast Bancshares, Inc.

Northpointe Bancshares, Inc.

Want to compare these IPOs side by side?

Compare Tool →

Related IPOs

Ticker	Company	Industry	IPO Date	IPO Price	Current	Return
CBK	Commercial Bancgroup, Inc.	Banks - Regional	Oct 2, 2025	$24.00	$29.17	+21.5%
NPB	Northpointe Bancshares, Inc.	Banks - Regional	Feb 14, 2025	$14.50	$17.69	+22.0%
CBNA	Chain Bridge Bancorp, Inc.	Banks - Regional	Oct 4, 2024	$22.00	$35.96	+63.5%
COYA	Coya Therapeutics, Inc.	Biotechnology	Dec 29, 2022	$5.00	$4.26	-14.8%
LIPO	Lipella Pharmaceuticals Inc.	Biotechnology	Dec 20, 2022	$5.75	$0.05	-99.1%
RAYA	Erayak Power Solution Group Inc.	Electrical Equipment & Parts	Dec 14, 2022	$4.00	$3.57	-10.8%
JEWL	Adamas One Corp.	Luxury Goods	Dec 9, 2022	$4.50	$0.00	-100.0%
ACRV	Acrivon Therapeutics, Inc.	Biotechnology	Nov 15, 2022	$12.50	$1.90	-84.8%